glp-1 and seizures Glucagon-like peptide-1 medicines in neurological psychiatric disorders: Cell Reports Medicine Glucagon-like peptide-1 (GLP-1) receptor agonists

Although its not yet confirmed if this risk applies to humans, individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 should avoid using tirzepatide

If you experience redness, itching, or swelling at the injection site , applying a cold compress for 10-15 minutes before injection can reduce the reaction

Do not stop your GLP-1 medication without consulting your prescriber

25 Although these replacements lower the affinity, ligands are made to correct the construction

acidophilus help balance the gut microbiome, enhance nutrient absorption, and promote long-term digestive comfort

On October 5, 2023, an important study, published in JAMA and authored by Mohit Sodhi, indicated an increased risk of gastroparesis, bowel obstruction, and pancreatitis for those using GLP-1 agonists